Back to School: How biopharma can reboot drug development. Access exclusive analysis here

UCB-Celltech pipeline

UCB-Celltech pipeline

Celltech
Product Indication Status Partner
Xyrem Treat symptoms of narcolepsy Awaiting EU approval Orphan Medical
CDP

Read the full 185 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE